Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Universal screening approach achieves a comparable detection rate of lung cancer

2.

Living in a more pedestrian-friendly area may reduce the risk of cancer and obesity-related diseases.

3.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

4.

Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.

5.

Loneliness and social isolation linked to heightened risk of death in those with cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot